Evidence map›Paper›PMID 42739691›Full record

ArticleJournal of clinical medicine2026

Is Baseline PET/CT-Derived Metabolic Tumor Burden Associated with Treatment Response and Survival in Hodgkin Lymphoma?

Büşra Tuğçe Tonyalı, Mehmet Günhan Tekin, Sefa Bayram, Selin Gül Yaran, Gökhan Burul, Edibe Sevde Eker, Tahir Alper Cinli, Hasan Göze, Burcu Esen Akkaş, Mesut Ayer

Abstract read
In one paragraph

Article in Journal of clinical medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Büşra Tuğçe TonyalıDepartment of Hematology, Başakşehir Çam and Sakura City Hospital, Istanbul 34480, Türkiye.ORCID 0000-0002-5821-9473
Mehmet Günhan TekinDepartment of Hematology, Başakşehir Çam and Sakura City Hospital, Istanbul 34480, Türkiye.ORCID 0000-0001-9293-844X
Sefa BayramDepartment of Nuclear Medicine, Başakşehir Çam and Sakura City Hospital, Istanbul 34480, Türkiye.ORCID 0000-0001-5144-0741
Selin Gül YaranDepartment of Nuclear Medicine, Başakşehir Çam and Sakura City Hospital, Istanbul 34480, Türkiye.ORCID 0009-0009-0824-2972
Gökhan BurulDepartment of Hematology, Başakşehir Çam and Sakura City Hospital, Istanbul 34480, Türkiye.ORCID 0000-0003-3702-536X
Edibe Sevde EkerDepartment of Hematology, Başakşehir Çam and Sakura City Hospital, Istanbul 34480, Türkiye.ORCID 0000-0002-3324-5923
Tahir Alper CinliDepartment of Hematology, Başakşehir Çam and Sakura City Hospital, Istanbul 34480, Türkiye.ORCID 0000-0003-2164-9776
Hasan GözeDepartment of Hematology, Başakşehir Çam and Sakura City Hospital, Istanbul 34480, Türkiye.ORCID 0000-0001-7397-1877
Burcu Esen AkkaşDepartment of Nuclear Medicine, Başakşehir Çam and Sakura City Hospital, Istanbul 34480, Türkiye.
Mesut AyerDepartment of Hematology, Başakşehir Çam and Sakura City Hospital, Istanbul 34480, Türkiye.ORCID 0000-0003-1977-0104

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Hodgkin lymphomametabolic tumor volumeoverall survivalPET/CTprogression-free survivaltotal lesion glycolysistreatment response

Identifiers

PMID42739691
PMCPMC13566709

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.